Broadening Horizons: Intestinal Microbiota As a Novel Biomarker and Potential Treatment for Hypertensive Disorders of Pregnancy

Overview

Journal Front Cell Infect Microbiol

Specialties Cell Biology
Infectious Diseases
Microbiology

Date 2024 Sep 6

PMID 39239636

Authors

Min Wang

Lianwen Zheng

Yang Meng

Shuai Ma

Donghai Zhao

Ying Xu

Affiliations

Soon will be listed here.

Abstract

Hypertensive disorders of pregnancy (HDP) are severe complications of pregnancy with high morbidity and are a major cause of increased maternal and infant morbidity and mortality. Currently, there is a lack of effective early diagnostic indicators and safe and effective preventive strategies for HDP in clinical practice, except for monitoring maternal blood pressure levels, the degree of proteinuria, organ involvement and fetal conditions. The intestinal microbiota consists of the gut flora and intestinal environment, which is the largest microecosystem of the human body and participates in material and energy metabolism, gene expression regulation, immunity regulation, and other functions. During pregnancy, due to changes in hormone levels and altered immune function, the intestinal microecological balance is affected, triggering HDP. A dysregulated intestinal microenvironment influences the composition and distribution of the gut flora and changes the intestinal barrier, driving beneficial or harmful bacterial metabolites and inflammatory responses to participate in the development of HDP and promote its malignant development. When the gut flora is dysbiotic and affects blood pressure, supplementation with probiotics and dietary fiber can be used to intervene. In this review, the interaction between the intestinal microbiota and HDP was investigated to explore the feasibility of the gut flora as a novel biomarker of HDP and to provide a new strategy and basis for the prevention and treatment of clinical HDP.

References

Gonzalez-Sarrias A, Romo-Vaquero M, Garcia-Villalba R, Cortes-Martin A, Selma M, Espin J . The Endotoxemia Marker Lipopolysaccharide-Binding Protein is Reduced in Overweight-Obese Subjects Consuming Pomegranate Extract by Modulating the Gut Microbiota: A Randomized Clinical Trial. Mol Nutr Food Res. 2018; 62(11):e1800160. DOI: 10.1002/mnfr.201800160. View

Pyne M, Bruder M, Moo-Young M, Chung D, Chou C . Technical guide for genetic advancement of underdeveloped and intractable Clostridium. Biotechnol Adv. 2014; 32(3):623-41. DOI: 10.1016/j.biotechadv.2014.04.003. View

Mokkala K, Houttu N, Koivuniemi E, Sorensen N, Nielsen H, Laitinen K . GlycA, a novel marker for low grade inflammation, reflects gut microbiome diversity and is more accurate than high sensitive CRP in reflecting metabolomic profile. Metabolomics. 2020; 16(7):76. PMC: 7306047. DOI: 10.1007/s11306-020-01695-x. View

Hadi A, Pourmasoumi M, Kazemi M, Najafgholizadeh A, Marx W . Efficacy of synbiotic interventions on blood pressure: a systematic review and meta-analysis of clinical trials. Crit Rev Food Sci Nutr. 2021; 62(20):5582-5591. DOI: 10.1080/10408398.2021.1888278. View

Segata N, Waldron L, Ballarini A, Narasimhan V, Jousson O, Huttenhower C . Metagenomic microbial community profiling using unique clade-specific marker genes. Nat Methods. 2012; 9(8):811-4. PMC: 3443552. DOI: 10.1038/nmeth.2066. View

Sun J, Wang F, Ling Z, Yu X, Chen W, Li H . Clostridium butyricum attenuates cerebral ischemia/reperfusion injury in diabetic mice via modulation of gut microbiota. Brain Res. 2016; 1642:180-188. DOI: 10.1016/j.brainres.2016.03.042. View

Wang W, Zhu L, Leng Y, Wang Y, Shi T, Wang W . Inflammatory Response: A Crucial Way for Gut Microbes to Regulate Cardiovascular Diseases. Nutrients. 2023; 15(3). PMC: 9921390. DOI: 10.3390/nu15030607. View

Pluznick J, Protzko R, Gevorgyan H, Peterlin Z, Sipos A, Han J . Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci U S A. 2013; 110(11):4410-5. PMC: 3600440. DOI: 10.1073/pnas.1215927110. View

Hsieh H, Chen Y, Hsu M, Yu H, Su C, Tain Y . Maternal Iron Deficiency Programs Offspring Cognition and Its Relationship with Gastrointestinal Microbiota and Metabolites. Int J Environ Res Public Health. 2020; 17(17). PMC: 7504367. DOI: 10.3390/ijerph17176070. View

10.

Lau K, Srivatsav V, Rizwan A, Nashed A, Liu R, Shen R . Bridging the Gap between Gut Microbial Dysbiosis and Cardiovascular Diseases. Nutrients. 2017; 9(8). PMC: 5579652. DOI: 10.3390/nu9080859. View

11.

Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View

12.

Wilck N, Matus M, Kearney S, Olesen S, Forslund K, Bartolomaeus H . Salt-responsive gut commensal modulates T17 axis and disease. Nature. 2017; 551(7682):585-589. PMC: 6070150. DOI: 10.1038/nature24628. View

13.

Kobyliak N, Virchenko O, Falalyeyeva T . Pathophysiological role of host microbiota in the development of obesity. Nutr J. 2016; 15:43. PMC: 4841968. DOI: 10.1186/s12937-016-0166-9. View

14.

Verhaar B, Prodan A, Nieuwdorp M, Muller M . Gut Microbiota in Hypertension and Atherosclerosis: A Review. Nutrients. 2020; 12(10). PMC: 7601560. DOI: 10.3390/nu12102982. View

15.

Liu M, Han Q, Yang J . Trimethylamine-N-oxide (TMAO) increased aquaporin-2 expression in spontaneously hypertensive rats. Clin Exp Hypertens. 2018; 41(4):312-322. DOI: 10.1080/10641963.2018.1481420. View

16.

Nutting C, Islam S, Daugirdas J . Vasorelaxant effects of short chain fatty acid salts in rat caudal artery. Am J Physiol. 1991; 261(2 Pt 2):H561-7. DOI: 10.1152/ajpheart.1991.261.2.H561. View

17.

Brennan C, Garrett W . Fusobacterium nucleatum - symbiont, opportunist and oncobacterium. Nat Rev Microbiol. 2018; 17(3):156-166. PMC: 6589823. DOI: 10.1038/s41579-018-0129-6. View

18.

Amarasekara R, Jayasekara R, Senanayake H, Dissanayake V . Microbiome of the placenta in pre-eclampsia supports the role of bacteria in the multifactorial cause of pre-eclampsia. J Obstet Gynaecol Res. 2014; 41(5):662-9. DOI: 10.1111/jog.12619. View

19.

Turnbaugh P, Ley R, Mahowald M, Magrini V, Mardis E, Gordon J . An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444(7122):1027-31. DOI: 10.1038/nature05414. View

20.

Chen T, Kim C, Kaur A, Lamothe L, Shaikh M, Keshavarzian A . Dietary fibre-based SCFA mixtures promote both protection and repair of intestinal epithelial barrier function in a Caco-2 cell model. Food Funct. 2017; 8(3):1166-1173. DOI: 10.1039/c6fo01532h. View